Anti-parkinsonian effects of ADX48621 a mGluR5 negative allosteric modulator, in the rat haloperidol induced catalepsy model

被引：0

作者：

Girard, F.

Keywood, C. ^{[1
]}

Poli, S. ^{[1
]}

Mutel, V. ^{[1
]}

机构：

[1] Addex Pharma SA, Plan Les Ouates, Switzerland

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：109 / 109

页数：1

共 24 条

[1] Anti-parkinsonian effects of ADX48621 a mGluR5 negative allosteric modulator, in the rat haloperidol induced catalepsy model
Girard, F.
Keywood, C.
Poli, S. P.
Mutel, V.
MOVEMENT DISORDERS, 2010, 25 (07) : S282 - S282
[2] Anti-parkinsonian and Anti-Dyskinetic Effects of Dipraglurant (ADX48621), a Novel mGluR5 Negative Allosteric Modulator in Clinical Development
Poli, Sonia
CURRENT NEUROPHARMACOLOGY, 2011, 9 : 53 - 54
[3] ADX48621, an MGluR5 negative allosteric modulator alleviates L-DOPA-induced chorea and dystonia in the MPTP-lesioned macaque model of Parkinson's disease
Keywood, C.
Hill, M.
Girard, F.
Bezard, E.
Poli, S.
Mutel, V.
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 96 - 96
[4] Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia
Schlumberger, Chantal
Pietraszek, Malgorzata
Gravius, Andreas
Danysz, Wojciech
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 95 (01) : 23 - 30
[5] ADX48621, a novel mGlu5 negative allosteric modulator alleviates L-DOPA-induced chorea and dystonia in the MPTP-lesioned macaque model of Parkinson's disease
Hill, M. P.
Girard, F.
Keywood, C.
Poli, S. -M.
Crossman, A. R.
Ravenscroft, P.
Li, Q.
Bezard, E.
Mutel, V.
MOVEMENT DISORDERS, 2010, 25 (07) : S281 - S282
[6] ADX10059 a Negative Allosteric Modulator of the Metabotropic Glutamate 5 Receptor (mGlur5) Effectively Controls Chorea and Dystonia in a Primate Model of Levodopa Induced Dyskinesia
Keywood, Charlotte G.
Bezard, Erwan
Girard, Francoise
Mutel, Vincent
NEUROLOGY, 2010, 74 (09) : A393 - A393
[7] The mGluR5 Negative Allosteric Modulator Dipraglurant Reduces Dyskinesia in the MPTP Macaque Model
Bezard, Erwan
Pioli, Elsa Y.
Li, Qin
Girard, Francoise
Mutel, Vincent
Keywood, Charlotte
Tison, Francois
Rascol, Olivier
Poli, Sonia M.
MOVEMENT DISORDERS, 2014, 29 (08) : 1074 - 1079
[8] Potential anxiolytic- and antidepressant-like activity of Dipraglurant (ADX48621), the novel negative allosteric modulator (NAM) of the metabotropic glutamate 5 (mGlu5) receptor
Podkowa, Karolina
Palucha-Poniewiera, Agnieszka
Poli, Sonia
Pilc, Andrzej
PHARMACOLOGICAL REPORTS, 2015, 67 : 34 - 35
[9] The mGlu4 receptor positive allosteric modulator, Lu AF21934, displays anti-parkinsonian effects in the haloperidol-treated rat model of Parkinson's disease
Johnston, T. H.
Uberti, M. A.
Bacolod, M. D.
Doller, D.
Brotchie, J. M.
MOVEMENT DISORDERS, 2012, 27 : S42 - S42
[10] The negative allosteric modulator of mGluR5, MPEP, potentiates the rewarding properties of cocaine in priming-induced reinstatement of CPP
Manzanedo, Carmen
Mateos-Garcia, Ana
Minarro, Jose
Carmen Arenas, M.
ADICCIONES, 2020, 32 (03) : 193 - 201

← 1 2 3 →